CELL COMMUNICATION & SIGNALLING
Chapter 3: RTK, NRTK, TGF-β Receptors & Associated Pathways
While GPCRs are like the cell's post office, **Enzyme-Linked Receptors** (like RTKs) are the master architects of cell growth, survival, and differentiation. They are the true heavyweights in cancer biology. Examiners will relentlessly test you on the **Ras-MAPK cascade**, the survival magic of **PI3K-AKT**, and the ultra-fast **JAK-STAT** cytokine pathway. We have streamlined these cascades so you can visualize and memorize them effortlessly. Let's dive in!
Quick Navigation Index
- 1. Introduction to Enzyme-Linked Receptors
- 2. Receptor Tyrosine Kinase (RTK) Structure & Activation
- 3. The Ras-MAPK Pathway (Growth)
- 4. The PI3K-AKT-mTOR Pathway (Survival)
- 5. The PLCγ Pathway (Calcium signalling)
- 6. Non-Receptor Tyrosine Kinases (NRTK) & JAK-STAT
- 7. TGF-β Receptors & Smad Proteins
- 8. High-Yield CSIR-NET / GATE Memory Tricks
- 9. Fun & High-Yield Master Quiz!
1. Introduction to Enzyme-Linked Receptors
These receptors are famous for controlling the cell cycle, immune responses, and development. They are single-pass transmembrane proteins, meaning they cross the lipid bilayer exactly once. There are three major superstar families we must master:
- Receptor Tyrosine Kinases (RTKs)
- Non-Receptor Tyrosine Kinases (NRTKs)
- TGF-β Serine/Threonine Kinase Receptors
2. Receptor Tyrosine Kinase (RTK) Activation
RTKs have their very own intrinsic kinase activity built directly into their intracellular tails. They act as receivers for almost all Growth Factors (EGF, PDGF, FGF) and Insulin.
The Universal RTK Activation Mechanism Must Know
1. Monomers wait: In the absence of a signal, RTKs float around the membrane as lonely, inactive monomers. 2. Ligand binds → Dimerization: The Growth Factor binds and forces two RTK monomers to physically hug each other (Dimerize). 3. Autophosphorylation: The two tails "wake up" and add phosphate groups to each other's Tyrosine residues. This is called trans-autophosphorylation. 4. Docking: The new phosphate tags act as perfectly shaped landing pads for intracellular adaptor proteins that contain SH2 or PTB domains (like Grb2 or PI3K).3. The Ras-MAPK Pathway (Growth)
This is arguably the most famous signalling cascade in biology. It is the primary engine for cell proliferation. If this pathway gets permanently stuck in the "ON" position, it causes Cancer.
↓
Grb2 (Adaptor with SH2 domain) binds the receptor
↓
Grb2 recruits SOS (a GEF)
↓
SOS forces Ras to drop GDP and pick up GTP
↓
Active Ras-GTP stimulates the Kinase Cascade:
Raf (MAPKKK) → MEK (MAPKK) → ERK (MAPK)
↓
ERK enters the nucleus and activates Transcription Factors (c-Fos, c-Myc)
Memory Tricks for Ras-MAPK
RME Cascade: Raf → MEK → ERK.
SOS is a GEF: Guanine Nucleotide Exchange Factor. It turns Ras ON.
GAP turns Ras OFF: GTPase Activating Protein forces Ras to hydrolyze GTP back to GDP. Mutations that disable GAP keep Ras permanently ON (causing cancer!).
4. The PI3K-AKT-mTOR Pathway (Survival)
If Ras is the accelerator for cell growth, the PI3K-AKT pathway is the cell's ultimate shield against death (Apoptosis). It promotes massive glucose uptake and protein synthesis.
The PI3K Survival Cascade
1. PI3K Activation: PI3K (Phosphoinositide 3-kinase) binds to the active RTK via its SH2 domain. 2. Lipid Phosphorylation: PI3K adds a phosphate to the membrane lipid PIP2, converting it into PIP3. 3. AKT Recruitment: PIP3 acts as a powerful docking site for AKT (Protein Kinase B) and PDK1. 4. mTOR Activation: Activated AKT blocks apoptosis (by inhibiting Bad and Caspase-9) and heavily stimulates mTOR, leading to massive protein synthesis and cell survival!The Nemesis: PTEN
PTEN is a crucial Tumor Suppressor. It acts as an eraser—it chops the phosphate off PIP3, converting it back into PIP2, shutting down the AKT survival signal. Loss of PTEN is a major driver of many cancers!
5. The PLCγ Pathway (Calcium signalling)
Wait, didn't we see Phospholipase C in the GPCR chapter? Yes! GPCRs use PLCβ. RTKs use PLCγ.
Pathway: The active RTK directly recruits and phosphorylates PLCγ (using its SH2 domain). PLCγ cleaves the membrane lipid PIP2 into two second messengers: IP3 and DAG. IP3 floods the ER to release Ca2+, and DAG+Ca2+ activate PKC.
6. Non-Receptor Tyrosine Kinases (NRTK) & JAK-STAT
NRTKs are cytoplasmic kinases. They DO NOT have a transmembrane domain. They sit just inside the cell membrane waiting for a receptor (that lacks its own kinase activity) to grab them.
| Feature | RTK | NRTK (e.g., Cytokine Receptors) |
|---|---|---|
| Transmembrane Domain | Yes | No (The kinase is separate from the receptor) |
| Intrinsic Kinase Activity | Yes (Built-in) | No (Recruits a separate kinase protein) |
| Classic Examples | Insulin, EGF, PDGF | JAK, Src, FAK, Abl |
The Ultra-Fast JAK-STAT Pathway Super Fast!
Used by Cytokines (Interferons, Interleukins), Growth Hormone, and Erythropoietin (EPO).
↓
JAKs (attached to the receptor) phosphorylate each other
↓
JAKs phosphorylate the receptor tails
↓
STAT proteins dock and get phosphorylated by JAK
↓
STATs dimerize, enter the Nucleus directly, and activate genes!
7. TGF-β Receptors & Smad Proteins
The Transforming Growth Factor-Beta (TGF-β) family uses a completely different type of kinase: Serine/Threonine Kinases (NOT Tyrosine!). They regulate development, wound healing, and extracellular matrix production.
The Smad Pathway
1. Receptor Activation: TGF-β binds the Type II receptor. The Type II receptor recruits, phosphorylates, and activates the Type I receptor. 2. Smad Activation: The Type I receptor phosphorylates R-Smads (Smad2 and Smad3). 3. Complex Formation: Smad2/3 bind to the Co-Smad (Smad4). 4. Transcription: The Smad complex enters the nucleus to regulate gene expression. (Note: Smad6 and Smad7 are Inhibitory I-Smads).8. High-Yield CSIR-NET / GATE Memory Tricks
- 1. RTKs dimerize and trans-autophosphorylate to create SH2/PTB docking sites.
- 2. Grb2 is the adaptor; SOS is the GEF that turns Ras ON (GDP → GTP).
- 3. The MAPK cascade is R-M-E: Raf → MEK → ERK.
- 4. PI3K creates PIP3; PTEN destroys PIP3. Both regulate the survival kinase AKT.
- 5. Rapamycin is a drug that specifically inhibits mTOR (blocking cell growth).
- 6. PLCγ is used by RTKs; PLCβ is used by GPCRs. Both create IP3 and DAG.
- 7. NRTKs (like JAK) are separate cytoplasmic proteins that associate with cytokine receptors.
- 8. In the JAK-STAT pathway, STAT dimers travel directly into the nucleus as transcription factors.
- 9. TGF-β receptors are Serine/Threonine kinases, NOT Tyrosine kinases.
- 10. Smad2 and Smad3 are phosphorylated by the TGF-β receptor, then bind to Smad4 to enter the nucleus.
9. Fun & High-Yield Master Quiz!
CSIR NET & GATE Master Quiz
Let's test those analytical skills! These 10 questions match the exact logic of high-level life science examinations. You've got this!
1. In the Ras-MAPK signaling cascade, what is the specific biochemical function of the SOS protein?
2. The PI3K-AKT pathway is heavily implicated in cancer cell survival and resistance to apoptosis. Which of the following proteins acts as a critical tumor suppressor by directly antagonizing PI3K activity?
3. Following ligand binding and autophosphorylation, Receptor Tyrosine Kinases (RTKs) recruit intracellular signaling proteins. These recruited proteins typically bind to the phosphorylated tyrosines via which specific protein domain?
4. How does the structure and initial activation of a Non-Receptor Tyrosine Kinase (NRTK) pathway, such as the JAK-STAT pathway, fundamentally differ from an RTK pathway?
5. In the TGF-β signaling pathway, the signal is carried from the activated cell surface receptors directly into the nucleus by which specific family of proteins?
6. Phospholipase C (PLC) is a critical enzyme that generates IP3 and DAG. While GPCRs typically activate the PLCβ isoform, RTKs directly activate which specific PLC isoform via their phosphorylated tails?
7. The MAP Kinase cascade is a highly conserved three-tiered kinase relay. Which of the following represents the correct sequential order of activation in this pathway?
8. What is the molecular consequence of a mutation in the Ras protein that completely abolishes its ability to interact with GAP (GTPase Activating Protein)?
9. In the JAK-STAT pathway, what must occur immediately after the STAT proteins are phosphorylated by the JAK kinases?
10. The drug Rapamycin is widely used as an immunosuppressant and anti-cancer agent. Which master regulatory protein in the PI3K-AKT survival pathway does Rapamycin specifically inhibit?
No comments:
Post a Comment